Antipsoriatic effects of avarol-3′-thiosalicylate are mediated by inhibition of TNF-α generation and NF-κB activation in mouse skin. - Amigó, M.; Payá, M.; De Rosa, S.; Terencio, M. C. (British Journal of Pharmacology, 2007)